Hamed submitted fraudulent PPP loan applications on behalf of several companies, overstating employee numbers, average ...

The FDA taps J&J drug teclistamab for its National Priority Voucher pilot, enabling expedited review for multiple myeloma treatment.

Federal officials said he reportedly submitted fraudulent PPP loan applications on behalf of multiple companies with which he ...

Yasir G. Hamed, 60, of Woodbridge, was also ordered to repay the fraudulently obtained funds and serve three years of ...

A center in South Africa processing applications for the United States refugee program was raided by immigration and law ...

The Commissioner’s National Priority Voucher program was launched in June to shorten review times for companies that align ...

Federal prosecutors alleged the company falsely certified eligibility for a $1 million COVID relief loan in 2020 despite franchise status making it ineligible.

The management company that owns the Michigan-based LaFontaine Automotive Group has agreed to pay $1.5 million to settle allegations that it fraudulently accepted COVID-19 era loans. The U.S. Attorney ...

The FDA has “proactively” granted Johnson & Johnson a coveted speedy review under the Commissioner’s National Priority ...

The inaugural approval under the program has gone to USAntibiotics and its domestically manufactured extended-release ...

Johnson & Johnson’s Tecvayli (teclistamab-cqyv), used in combination with daratumumab to treat relapsed or refractory multiple myeloma, has received FDA’s latest national priority voucher, becoming ...

FDA grants 1st approval under priority voucher program to Augmentin XR, expediting review and supporting U.S. antibiotic supply chain resilience.